Objectives: Infertility affects approximately 80 million people worldwide. The prevalence of the disease ranges from 8-10% among developed countries. Infertility poses an increased challenge however, there are several medical interventions could be identified that could contribute to the successful conception. The aim of our study was to determine the epidemiological disease burden of unspecified female infertility in Hungary.

Methods: Data were derived from the financial database of the Hungarian National Health Insurance Fund Administration (NHIFA), for the year 2019. Database included annual number of patients, number of cases and prevalence of the utilization per 100,000 population according to age groups. The following health insurance treatment categories were included into our study: general practice care, home care, in- and outpatient care, medical imaging, laboratory diagnostics, pharmaceuticals and medical aids. Patients with unspecified female infertility were identified with the following code of the International Classification of Diseases 10^th revision: N9790.

Results: The highest number of patients were found in outpatient care (26,160 women), followed by pharmaceuticals (15,914 women), and laboratory diagnostics (12,797 women). The mean age of the patients was 35.4 years in outpatient care. Based on number of patients related to outpatient care the prevalence among women was 512.3 patients in 100,000 inhabitants. Age specific prevalence was the highest within the age group of 30-39 years (2,248.62 women) and the group of 20-29 years (952.15 women).

Conclusions: The results showed that the highest number of patients was in outpatient care. The prevalence of unspecified female infertility showed significant differences by age groups. The most affected age group was women aged 30-39 years, which was 2.3 times higher than the number of patients of 20-29 years age group. Thus early diagnosis, proper medical intervention and medication affect the successful childbearing and the quality of life of women.